Neural Regeneration Research,
Год журнала:
2024,
Номер
20(6), С. 1599 - 1612
Опубликована: Июнь 26, 2024
Tanycytes,
specialized
ependymal
cells
located
in
the
hypothalamus,
play
a
crucial
role
generation
of
new
neurons
that
contribute
to
neural
circuits
responsible
for
regulating
systemic
energy
balance.
The
precise
coordination
gene
networks
controlling
neurogenesis
naive
and
mature
tanycytes
is
essential
maintaining
homeostasis
adulthood.
However,
our
understanding
molecular
mechanisms
signaling
pathways
govern
proliferation
differentiation
into
remains
limited.
This
article
aims
review
recent
advancements
research
functions
tanycyte-derived
neurogenesis.
Studies
employing
lineage-tracing
techniques
have
revealed
specifically
originating
from
hypothalamus
has
compensatory
neuronal
loss
helps
maintain
during
metabolic
diseases.
Intriguingly,
disorders
are
considered
early
biomarkers
Alzheimer's
disease.
Furthermore,
neurogenic
potential
state
newborn
derived
heavily
depend
on
maintenance
mild
microenvironments,
which
may
be
disrupted
disease
due
impaired
blood-brain
barrier
function.
specific
alterations
regulatory
governing
remain
unclear.
Accumulating
evidence
suggests
might
disease,
exacerbating
neurodegeneration.
Confirming
this
hypothesis,
however,
poses
challenge
because
lack
long-term
tracing
nucleus-specific
analyses
patients
with
Further
underlying
holds
promise
identifying
small
molecules
capable
restoring
tanycyte
neurodegenerative
line
investigation
could
provide
valuable
insights
therapeutic
strategies
related
conditions.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(6), С. 2825 - 2825
Опубликована: Март 20, 2025
Fragile-X-associated
tremor/ataxia
syndrome
(FXTAS)
is
a
progressive
neurodegenerative
disorder
associated
with
the
FMR1
gene
premutation,
characterized
by
presence
of
55
to
200
CGG
triplet
repeat
expansions.
Although
initial
symptoms
FXTAS
typically
manifest
in
males
around
age
60
motor
and
cognitive
deficits,
presentation
progression
females
differ.
Women,
fact,
exhibit
higher
prevalence
neuropsychiatric
symptoms,
an
earlier
onset
compared
observed
men.
The
following
article
reports
on
ten
cases
women
diagnosis
originating
from
two
medical
centers.
All
study
exhibited
subtle
neurological
signs
as
common
features.
Symptoms
male
population,
such
tremors
cerebellar
ataxia,
were
either
absent
or
significantly
reduced
female
cohort.
Conversely,
there
was
among
women.
Neurocognitive
impairment
only
minimally
evident,
mild
executive
dysfunction
memory
complaints
noted
subset
cases.
For
this
reason,
we
propose
terminology
preFXTAS
prodromic
define
clinical
early
manifestations
that
do
not
entirely
fulfill
established
diagnostic
criteria
but
MRI
evidence
white
matter
alterations
suggesting
initiation
disease
process.
underscores
importance
establishing
new
for
and,
at
same
time,
developing
biomarkers
interview
checklists/assessment
scales
dedicated
females.
Genes,
Год журнала:
2025,
Номер
16(4), С. 365 - 365
Опубликована: Март 22, 2025
Background:
Metformin
is
a
widely
used
oral
hypoglycemic
agent
for
treating
type
2
diabetes.
Planarians,
with
their
remarkable
regenerative
abilities,
are
frequently
employed
as
model
organisms
in
stem
cell
and
regeneration
studies.
This
study
aimed
to
investigate
the
effects
of
metformin
on
planarian
regeneration,
focusing
eyespots
after
amputation.
Methods:
Regenerating
planarians
amputated
were
exposed
various
concentrations
metformin.
The
time
was
measured
assess
Subsequently,
1
mmol/L
treatment
24
h
applied
planarians,
followed
by
transcriptome
analysis
identify
differentially
expressed
genes
(DEGs).
gene
expression
validated
through
qPCR.
full-length
casein
kinase
1α
(DjCK1α)
cloned
using
RACE
technology.
DjCK1α
interference
performed
examine
its
role
regeneration.
Results:
Low
significantly
reduced
planarians.
Transcriptome
identified
113
DEGs,
including
61
upregulated
52
downregulated
genes.
GO
KEGG
enrichment
analyses
conducted.
Notably,
DjCK1α,
key
involved
selected
further
validation.
qPCR
confirmed
that
upregulated.
prolonged
cultured
water,
while
did
not
promote
eyespot
DjCK1α-interfered
Conclusions:
results
suggest
accelerates
potentially
regulation
DjCK1α.
provides
first
transcriptome-based
drug
highlighting
process.
Pharmaceuticals,
Год журнала:
2025,
Номер
18(4), С. 486 - 486
Опубликована: Март 28, 2025
This
comprehensive
review
examines
the
therapeutic
potential
of
metformin,
a
well-established
diabetes
medication,
in
treating
neurodegenerative
disorders.
Originally
used
as
first-line
treatment
for
type
2
diabetes,
recent
studies
have
begun
investigating
metformin’s
effects
beyond
metabolic
disorders,
particularly
its
neuroprotective
capabilities
against
conditions
like
Parkinson’s
disease,
Alzheimer’s
Huntington’s
and
multiple
sclerosis.
Key
findings
demonstrate
that
operate
through
pathways:
AMPK
activation
enhancing
cellular
energy
metabolism
autophagy;
upregulation
antioxidant
defenses;
suppression
inflammation;
inhibition
protein
aggregation;
improvement
mitochondrial
function.
These
mechanisms
collectively
address
common
pathological
features
neurodegeneration
neuroinflammation,
including
oxidative
stress,
accumulation,
dysfunction.
Clinical
preclinical
evidence
supporting
association
with
improved
cognitive
performance,
reduced
risk
dementia,
modulation
hallmarks
diseases
is
critically
evaluated.
While
metformin
shows
promise
agent,
this
emphasizes
need
further
investigation
to
fully
understand
optimal
applications
diseases.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(7), С. 3140 - 3140
Опубликована: Март 28, 2025
Gestational
diabetes
mellitus
(GD)-induced
gut
dysbiosis
in
pregnant
mothers
may
increase
the
risk
of
cognitive
impairment
and
neurological
disorders
both
mother
offspring
as
they
age.
Restoring
balance
could
improve
outcomes
for
both.
Despite
advancements
GD
treatment,
side
effects
have
increased,
long-term
neurocognitive
impacts
on
born
to
remain
underexplored.
This
study
uses
a
mouse
model,
inducing
pancreatic
dysfunction
3-month-old
C57BL/6J
mice
with
Streptozotocin.
The
efficacy
mechanism
prebiotic
phytocompound
green
leaf
extract
(Allmania
nodiflora)
were
assessed,
metformin
standard.
dams
exhibited
weight
glucose
reduction,
IL-6
elevation,
GLUT3
astroglia
changes
cerebral
cortex,
barrier
impairment,
heightened
anxiety
compared
controls.
Bacterial
16s
rRNA
sequencing
revealed
dysbiosis,
reduced
Erysipelotrichales
Metformin
lowered
blood
levels
but
failed
rescue
functional
behavioral
phenotypes
offspring.
Phytocompound
treatment
improved
glucose,
inflammation,
integrity,
reversed
enhanced
brain
health.
It
rescued
deficits
offspring,
suggesting
be
more
effective
therapeutic
agent
humans.
Journal of Neuroinflammation,
Год журнала:
2024,
Номер
21(1)
Опубликована: Дек. 3, 2024
Chronic
migraine
(CM)
is
a
serious
neurological
disorder.
Central
sensitization
one
of
the
important
pathophysiological
mechanisms
underlying
CM,
and
microglia-induced
neuroinflammation
conduces
to
central
sensitization.
Triggering
receptor
expressed
on
myeloid
cells
2
(TREM2)
presented
solely
in
microglia
residing
within
nervous
system
plays
key
role
neuroinflammation.
Metformin
has
been
shown
regulate
inflammatory
responses
exert
analgesic
effects,
but
its
relationship
with
CM
remains
unclear.
In
study,
we
investigated
whether
metformin
modulates
TREM2
improve
clarified
potential
molecular
mechanisms.
A
mouse
model
was
induced
by
administration
nitroglycerin
(NTG).
Behavioral
evaluations
were
conducted
using
von
Frey
filaments
hot
plate
experiments.
Western
blot
immunofluorescence
techniques
employed
investigate
SYK
inhibitor
R406
administered
mice
assess
their
regulatory
effects
To
explore
TREM2-SYK
regulating
metformin,
lentivirus
encoding
injected
into
trigeminal
nucleus
caudalis
(TNC).
vitro
experiments
evaluate
regulation
involving
interventions
LPS,
R406,
siTREM2,
plasmids.
pretreatment
can
effectively
hyperalgesia
mice.
Both
significantly
inhibit
c-fos
CGRP
expression
mice,
suppressing
activation
NLRP3
inflammasome
NTG.
With
NTG,
gradually
increased
TNC
microglia.
Additionally,
observed
that
inhibits
Lv-TREM2
attenuated
metformin-mediated
anti-inflammatory
responses.
experiments,
knockdown
inhibited
LPS-induced
pathway
alleviated
After
sole
overexpression
TREM2,
signaling
activated,
resulting
an
pro-inflammatory
cytokines;
nevertheless,
this
consequence
be
reversed
R406.
The
attenuates
inhibition
activity
mediated
effect
Our
findings
suggest
through
pathway.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(21), С. 11357 - 11357
Опубликована: Окт. 22, 2024
Neovascular
age-related
macular
degeneration
(nAMD),
a
leading
cause
of
blindness
in
older
adults,
presents
challenging
pathophysiology
involving
choroidal
neovascularization
(CNV)
and
retinal
degeneration.
Current
treatments
relying
on
intravitreal
(IVT)
administration
anti-angiogenic
agents
are
costly
moderate
effectiveness.
Metformin,
the
common
anti-diabetic
drug,
has
been
associated
with
decreased
odds
developing
AMD.
Studies
have
shown
that
metformin
can
mitigate
cellular
aging,
neoangiogenesis,
inflammation
across
multiple
diseases.
This
preclinical
study
assessed
metformin's
impact
vessel
growth
using
explants
before
exploring
IVT
effects
laser-induced
CNV
light-induced
C57BL/6J
BALB/cJ
mice,
respectively.
Metformin
reduced
new
dose-dependent
relationship.
Following
laser
induction,
suppressed
peripheral
infiltration
IBA1
Biomolecules,
Год журнала:
2024,
Номер
14(12), С. 1579 - 1579
Опубликована: Дек. 10, 2024
Nervous
system
diseases
represent
a
significant
global
burden,
affecting
approximately
16%
of
the
world’s
population
and
leading
to
disability
mortality.
These
conditions,
encompassing
both
central
nervous
(CNS)
peripheral
(PNS)
disorders,
have
substantial
social
economic
impacts.
Metformin,
guanidine
derivative
derived
from
plant
source,
exhibits
therapeutic
properties
in
various
health
conditions
such
as
cancer,
aging,
immune-related
polycystic
ovary
syndrome,
cardiovascular
ailments,
more.
Recent
studies
highlight
metformin’s
ability
cross
blood–brain
barrier,
stimulate
neurogenesis,
provide
beneficial
effects
specific
neurological
disorders
through
diverse
mechanisms.
This
review
discusses
advancements
research
on
role
mechanisms
treating
within
systems,
aiming
facilitate
further
investigation,
utilization,
clinical
application
metformin
neurology.